Dosimetric optimization of therapy of metastatic differentiated thyroid cancer with124I PET: initial results of an ongoing phase II trial

被引：0
|
作者：
Chiesa, C. [1 ]
Gorgoni, G. [2 ]
Rubino, F. [1 ]
Olivari, L. [2 ]
Mazzaglia, S. [1 ]
Severi, F. [2 ]
Bagnalasta, M. [1 ]
Kirienko, M. [1 ]
Fuoco, V. [1 ]
Alessi, A. [1 ]
Lorenzoni, A. [1 ]
Borrello, M. [1 ]
Brusa, A. [1 ]
Rodari, M. [3 ]
Rubino, M. [4 ]
Massri, K. [5 ]
Zerbini, F. [6 ]
Muni, A. [7 ]
Pomposelli, E. [7 ]
Maggiore, R. [8 ]
Chiti, A. [8 ,9 ]
Grappeja, L. [10 ]
Seregni, E. [1 ]
Salgarello, M. [2 ]
Maccauro, M. [1 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[2] IRCCS Sacro Cuore Don Calabria, Negrar, Italy
[3] Humanitas Clin Inst, Rozzano, Italy
[4] European Inst Oncol, Milan, Italy
[5] Legnano Gen Hosp, Legnano, Italy
[6] Policlin Monza, Monza, Italy
[7] Azienda Osped Nazl SS Antonio & Biagio & Cesare A, Alessandria, Italy
[8] IRCCS Osped San Raffaele, Milan, Italy
[9] Univ Vita Salute San Raffaele, Fac Med & Surg, Milan, Italy
[10] Univ Milan, Specializat Sch Nucl Med, Milan, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0945
引用
收藏
页码：S810 / S810
页数：1
相关论文
共 50 条
  • [31] Lesion dose in differentiated thyroid carcinoma metastases after rhTSH or thyroid hormone withdrawal: 124I PET/CT dosimetric comparisons
    Freudenberg, Lutz Stefan
    Jentzen, Walter
    Petrich, Thorsten
    Froemke, Cornelia
    Marlowe, Robert J.
    Heusner, Till
    Brandau, Wolfgang
    Knapp, Wolfram H.
    Bockisch, Andreas
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (12) : 2267 - 2276
  • [32] Lesion dose in differentiated thyroid carcinoma metastases after rhTSH or thyroid hormone withdrawal: 124I PET/CT dosimetric comparisons
    Lutz Stefan Freudenberg
    Walter Jentzen
    Thorsten Petrich
    Cornelia Frömke
    Robert J. Marlowe
    Till Heusner
    Wolfgang Brandau
    Wolfram H. Knapp
    Andreas Bockisch
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 2267 - 2276
  • [33] Radioiodine therapy (RAIT) guided by 124I-PET/CT imaging in metastatic differentiated thyroid cancer (DTC): long-term follow-up of patients recruited in a prospective trial
    Rizzini, E. Lodi
    Pettinato, C.
    Zanoni, L.
    Allegri, V.
    Tabacchi, E.
    Repaci, A.
    Morganti, A. G.
    Fanti, S.
    Monari, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S30 - S30
  • [34] Can the 124I dosimetry in a patient affected by metastatic Differentiated Thyroid Cancer predict the effectivness of 131I therapy in the metastases?
    Rossi, G.
    Camarda, M.
    Montani, L.
    Brianzoni, E.
    Ancidei, S.
    Barucca, S.
    Berbellini, A.
    Capoccetti, F.
    Criscuoli, B.
    Ferretti, F.
    Manni, C.
    Nicoli, P. S.
    Remediani, S.
    Fattori, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S180 - S181
  • [35] Case report: unveiling an infrequent metastatic site in differentiated thyroid cancer with iodine-124 PET/CT
    Valenzuela, D.
    Jewell, K.
    Cardin, A.
    Alipour, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S887 - S888
  • [36] Quantitative performance evaluation of 124I PET/MRI lesion dosimetry in differentiated thyroid cancer
    Wierts, R.
    Jentzen, W.
    Quick, H. H.
    Wisselink, H. J.
    Pooters, I. N. A.
    Wildberger, J. E.
    Herrmann, K.
    Kemerink, G. J.
    Backes, W. H.
    Mottaghy, F. M.
    PHYSICS IN MEDICINE AND BIOLOGY, 2018, 63 (01):
  • [37] 124I PET/CT in Patients with Differentiated Thyroid Cancer: Clinical and Quantitative Image Analysis
    Gulec, Seza A.
    Kuker, Russ A.
    Goryawala, Mohammed
    Fernandez, Carlos
    Perez, Rudolfo
    Khan-Ghany, Alina
    Apaza, Ana
    Harja, Evis
    Harrell, Mack
    THYROID, 2016, 26 (03) : 441 - 448
  • [38] Initial results from a phase 2 trial of AMG 706 in patients (Pts) with differentiated thyroid cancer (DTC)
    Sherman, S.
    Schlumberger, M.
    Droz, J. P.
    Hofmann, M.
    Wirth, L.
    Bastholt, L.
    Martins, R.
    Licitra, L.
    Shi, Y.
    Stepan, D.
    HORMONE RESEARCH, 2007, 68 : 4 - 5
  • [39] Donafenib in Progressive Locally Advanced or Metastatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Results of a Randomized, Multicenter Phase II Trial
    Lin, Yan-Song
    Yang, Hui
    Ding, Yong
    Cheng, Yi-Zhuang
    Shi, Feng
    Tan, Jian
    Deng, Zhi-Yong
    Chen, Zhen-Dong
    Wang, Rong-Fu
    Ji, Qing-Hai
    Huang, Rui
    Li, Lin-Fa
    THYROID, 2021, 31 (04) : 607 - 615
  • [40] MERAIODE: A Phase II Redifferentiation Trial with Trametinib and 131I in Metastatic Radioactive Iodine Refractory RAS Mutated Differentiated Thyroid Cancer
    Leboulleux, Sophie
    Benisvy, Daniele
    Taieb, David
    Attard, Marie
    Bournaud, Claire
    Terroir-Cassou-Mounat, Marie
    Lacroix, Ludovic
    Anizan, Nadege
    Schiazza, Aurelie
    Garcia, Marie Eve
    Al Ghuzlan, Abir
    Lamartina, Livia
    Schlumberger, Martin
    Godbert, Yann
    Borget, Isabelle
    THYROID, 2023, 33 (09) : 1124 - 1129
12345